CNS

CENTRAL NERVOUS SYSTEM

One in 10 people, age 65 and older has Alzheimer’s dementia – 1 in 10

Alzheimer’s is just one of the devastating conditions that affects the Central Nervous System (CNS).   Along with other conditions such as Huntington’s disease, ADHD, epilepsy, depression and numerous pain disorders, Alzheimer’s can have varying degrees of influence on not only your quality of life but also the lives of those around you.  

We understand the impact a CNS condition can have on a patient and their family.  At ProTrials we are committed to furthering research solutions in this important therapeutic area.  Over 40% of our staff has experience in the CNS field. We have worked in all Phases of CNS drug development and in studies with a broad range of CNS indications.  Through our partnering with experienced and respected CNS research professionals, we can provide a therapeutically focused team to meet and exceed your goals.

40%

of all staff with CNS Experience

Includes Project Management, Regional Monitoring, Data Management, Vendor and Program Management, and Clinical Trial Assistance

  1. 40+

    studies conducted to date

    • Phases I, II, III, and IV
  1. 13+

    Indications

  2. Top Areas:
    • Alzheimer’s Disease
    • Adult Upper & Lower Limb Spasticity
    • Huntington’s Disease
    • Pain

Indications

  • Attention Deficit Hyperactivity Disorder
  • Adult Upper & Lower Limb Spasticity
  • Alzheimer’s Disease
  • Chronic Pain in Osteoarthritis
  • Complement Mediated Neurodegenerative Diseases
  • Depression
  • Ear, Nose and Throat Surgery
  • Huntington’s Disease
  • Intrathecal Injection
  • Mild Headaches
  • Opioid Dependence
  • Pain
  • Progressive Myoclonic Epilepsy